| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 339.85M | 472.25M | 1.08B | 270.62M | -12.76M |
| Gross Profit | 193.77M | 341.23M | 1.06B | 195.62M | -18.05M |
| EBITDA | 239.98M | 253.59M | 821.19M | 113.38M | 0.00 |
| Net Income | 63.88M | 146.48M | 610.52M | 30.51M | -56.43M |
Balance Sheet | |||||
| Total Assets | 6.64B | 6.18B | 5.84B | 4.29B | 3.52B |
| Cash, Cash Equivalents and Short-Term Investments | 656.16M | 548.95M | 328.11M | 107.66M | 180.25M |
| Total Debt | 2.15B | 1.78B | 1.55B | 1.27B | 1.03B |
| Total Liabilities | 3.51B | 2.92B | 2.63B | 1.90B | 1.58B |
| Stockholders Equity | 2.45B | 2.42B | 2.29B | 1.74B | 1.55B |
Cash Flow | |||||
| Free Cash Flow | -29.91M | 216.06M | -277.89M | -466.51M | -585.65M |
| Operating Cash Flow | -29.62M | 216.72M | -274.68M | -466.10M | -585.36M |
| Investing Cash Flow | -8.98M | -661.00K | -3.21M | -407.00K | -285.00K |
| Financing Cash Flow | 135.19M | 33.83M | 389.53M | 399.13M | 444.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £27.35B | 3.00 | 23.76% | 2.44% | 62.80% | 48.86% | |
76 Outperform | £1.70B | ― | 2.22% | 2.40% | 64.34% | 77.61% | |
71 Outperform | £478.21M | 10.05 | 9.58% | 5.79% | 82.69% | 21.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £4.47B | 5.37 | 23.35% | 4.13% | 28.34% | 44.04% | |
54 Neutral | £2.05B | 56.55 | 4.25% | 2.85% | 62.91% | -15.13% | |
52 Neutral | £682.79M | 30.74 | 2.49% | 1.22% | -37.43% | -67.39% |